BMO Capital lowered the firm’s price target on Kinaxis to C$190 from C$215 and keeps an Outperform rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KXSCF: